Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:09:34 UTC |
---|
Update Date | 2019-07-23 07:15:28 UTC |
---|
HMDB ID | HMDB0060959 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 4'-N-desmethylolanzapine |
---|
Description | 4'-N-desmethylolanzapine is a metabolite of olanzapine. Olanzapine (trade name Zyprexa or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine, but is classified as a thienobenzodiazepine. The olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company; the drug went generic in 2011. Sales of Zyprexa in 2008 were $2.2B in the US alone, and $4.7B in total. (Wikipedia) |
---|
Structure | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCNCC2)S1 InChI=1S/C16H18N4S/c1-11-10-12-15(20-8-6-17-7-9-20)18-13-4-2-3-5-14(13)19-16(12)21-11/h2-5,10,17,19H,6-9H2,1H3 |
---|
Synonyms | Value | Source |
---|
4-Desmethylolanzapine | HMDB | N-Desmethylolanzapine | MeSH | Desmethylolanzapine | MeSH | N-Desmethyl-olanzapine | MeSH |
|
---|
Chemical Formula | C16H18N4S |
---|
Average Molecular Weight | 298.406 |
---|
Monoisotopic Molecular Weight | 298.125217286 |
---|
IUPAC Name | 5-methyl-8-(piperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),5,8,10,12-hexaene |
---|
Traditional Name | 5-methyl-8-(piperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),5,8,10,12-hexaene |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCNCC2)S1 |
---|
InChI Identifier | InChI=1S/C16H18N4S/c1-11-10-12-15(20-8-6-17-7-9-20)18-13-4-2-3-5-14(13)19-16(12)21-11/h2-5,10,17,19H,6-9H2,1H3 |
---|
InChI Key | FHPIXVHJEIZKJW-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | Not Available |
---|
Direct Parent | Benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - Benzodiazepine
- Thieno-para-diazepine
- 2,3,5-trisubstituted thiophene
- Para-diazepine
- N-arylated-2-aminothiophene
- 1,4-diazinane
- Piperazine
- 2-aminothiophene
- Imidolactam
- Benzenoid
- Heteroaromatic compound
- Thiophene
- Amidine
- Azacycle
- Secondary amine
- Secondary aliphatic amine
- Carboxylic acid amidine
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic nitrogen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
4'-N-desmethylolanzapine,1TMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=CC=C1N=C2N1CCNCC1 | 2801.8 | Semi standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=CC=C1N=C2N1CCNCC1 | 2694.3 | Standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=CC=C1N=C2N1CCNCC1 | 4175.7 | Standard polar | 33892256 | 4'-N-desmethylolanzapine,1TMS,isomer #2 | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN([Si](C)(C)C)CC2)S1 | 3015.4 | Semi standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TMS,isomer #2 | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN([Si](C)(C)C)CC2)S1 | 2923.8 | Standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TMS,isomer #2 | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN([Si](C)(C)C)CC2)S1 | 4585.5 | Standard polar | 33892256 | 4'-N-desmethylolanzapine,2TMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=CC=C1N=C2N1CCN([Si](C)(C)C)CC1 | 2900.8 | Semi standard non polar | 33892256 | 4'-N-desmethylolanzapine,2TMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=CC=C1N=C2N1CCN([Si](C)(C)C)CC1 | 2950.8 | Standard non polar | 33892256 | 4'-N-desmethylolanzapine,2TMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C)C1=CC=CC=C1N=C2N1CCN([Si](C)(C)C)CC1 | 3987.8 | Standard polar | 33892256 | 4'-N-desmethylolanzapine,1TBDMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C1N=C2N1CCNCC1 | 2964.0 | Semi standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TBDMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C1N=C2N1CCNCC1 | 2892.4 | Standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TBDMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C1N=C2N1CCNCC1 | 4218.7 | Standard polar | 33892256 | 4'-N-desmethylolanzapine,1TBDMS,isomer #2 | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN([Si](C)(C)C(C)(C)C)CC2)S1 | 3239.5 | Semi standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TBDMS,isomer #2 | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN([Si](C)(C)C(C)(C)C)CC2)S1 | 3116.6 | Standard non polar | 33892256 | 4'-N-desmethylolanzapine,1TBDMS,isomer #2 | CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN([Si](C)(C)C(C)(C)C)CC2)S1 | 4820.6 | Standard polar | 33892256 | 4'-N-desmethylolanzapine,2TBDMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C1N=C2N1CCN([Si](C)(C)C(C)(C)C)CC1 | 3279.5 | Semi standard non polar | 33892256 | 4'-N-desmethylolanzapine,2TBDMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C1N=C2N1CCN([Si](C)(C)C(C)(C)C)CC1 | 3340.5 | Standard non polar | 33892256 | 4'-N-desmethylolanzapine,2TBDMS,isomer #1 | CC1=CC2=C(S1)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C1N=C2N1CCN([Si](C)(C)C(C)(C)C)CC1 | 4113.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 4'-N-desmethylolanzapine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001c-9080000000-faa8849c72b6d869bd37 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 4'-N-desmethylolanzapine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 10V, Positive-QTOF | splash10-0002-0090000000-e6173f65a5be854020d4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 20V, Positive-QTOF | splash10-0002-0090000000-c07ba5509b5f363be715 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 40V, Positive-QTOF | splash10-0002-9410000000-5677fd4bc90081f13b65 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 10V, Negative-QTOF | splash10-0002-0090000000-091ff8e9e22b3d41c509 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 20V, Negative-QTOF | splash10-0a4i-0090000000-dc8ea6f0e8d2788f620f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 40V, Negative-QTOF | splash10-0006-9340000000-f4df07581c100ebfad1a | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 10V, Positive-QTOF | splash10-0002-0090000000-b3cb1faf775243f00caf | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 20V, Positive-QTOF | splash10-0002-0090000000-b3cb1faf775243f00caf | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 40V, Positive-QTOF | splash10-01ox-2190000000-c3e7182e256251f3c25b | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 10V, Negative-QTOF | splash10-0002-0090000000-26a389783719b34ab6fe | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 20V, Negative-QTOF | splash10-0002-0090000000-26a389783719b34ab6fe | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4'-N-desmethylolanzapine 40V, Negative-QTOF | splash10-03gl-2390000000-04ea41e24be59b5d9741 | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|